#United States #New York #AI-native #Amperos Health #Denial Management

Amperos Health Secures Groundbreaking Investment

Amperos Health has made headlines by announcing a significant achievement in its efforts to transform healthcare revenue cycle management. The innovative company, recognized as the first insurance revenue recovery partner fully utilizing AI for handling denials end-to-end, has recently closed a $16 million Series A funding round. This was led by Bessemer Venture Partners, with support from Uncork Capital and Neo, marking a pivotal moment for the startup as it aims to launch the industry's first AI-native denial management and revenue recovery solution for healthcare providers.

This funding comes at a crucial time when denial rates in healthcare are escalating. According to recent statistics, a staggering 12% of claims were denied in 2024, leading to an estimated loss of $262 billion in revenue for healthcare providers. The burden of recovering these denied claims also weighs heavily, with providers allocating more than $26 billion annually toward this effort, despite 70% of these claims ultimately being paid out. Alarmingly, many revenue cycle management (RCM) teams are understaffed, facing a high turnover rate—32% annually—which exacerbates the issue.

Amperos aims to address these challenges head-on. By providing an innovative solution that automates the entire denial management process from beginning to end, Amperos enhances efficiency in recovering denied claims and provides valuable insights into optimizing billing processes. The firm's technology has already made a significant impact, serving over 3,000 clinical locations across all 50 states and recovering nearly $700 million per year from more than 500,000 claims.

Michal Miernowski, the CEO and Co-Founder of Amperos Health, emphasizes the importance of simplifying the revenue cycle management process. In his statement, he expressed, "Complexity in healthcare revenue cycle management (RCM) should not be the norm, and our mission at Amperos is to streamline the denial and collections process. This allows providers to concentrate on what truly matters—operating their practices and caring for their patients."

The new funding will enable Amperos to further develop its analytics capabilities, expand its reach to more healthcare providers, and roll out advanced features in other RCM workflows. With increasing demands in the healthcare sector, the innovative approach taken by Amperos is timely and necessary.

As Sofia Guerra, a Partner at Bessemer Venture Partners, notes, "Denials are one of healthcare's fastest-growing pain points—claims are denied at an increasing rate, resulting in hundreds of billions in lost revenue. The existing processes are broken and ready for AI transformation. What distinguishes Amperos is their true agentic AI platform that automates this workflow end-to-end without handoffs or gaps. The results are remarkable, with 22% more revenue recovered per claim at up to 50% lower costs. This innovation offers real financial relief, especially for providers operating with razor-thin margins."

Unlike other market solutions that only automate parts of the denial management process, Amperos is the first to offer a comprehensive platform that integrates all workflows, covering everything from submission to follow-up. They leverage cutting-edge language models and artificial intelligence technologies to enhance efficiencies across the entire revenue cycle.

Testimonies from clients highlight the effectiveness of Amperos' solution. Valerie DeCaro, Vice President of Revenue Cycle Management at DOCS Dermatology, remarked on the significant relief the partnership has provided: "Our alliance with Amperos has tremendously alleviated the burden associated with recovering unpaid claims and insurance collections. We've managed to recover 24% more claims without increasing our headcount, enabling us to focus on higher-complexity needs." This powerful impact underpins Amperos's commitment to supporting healthcare providers.

With a foundation of $4.2 million in seed funding announced in June 2025, Amperos Health is on the path to redefining healthcare revenue cycle management. By challenging the notion that RCM is inherently complex, they aim to set a new standard where providers can navigate the revenue cycle with ease and confidence.

To learn more about Amperos Health and its innovative AI-native solutions, visit their official website at www.amperos.com.